Inhibition of arachidonic acid metabolism in the perinatal period: pharmacology, clinical application, and potential adverse effects.
D000284:Administration, Oral; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000037:antagonists & inhibitors*; D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors; D004311:Double-Blind Method; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010974:Platelet Aggregation / Q000187:drug effects; D011247:Pregnancy; D011652:Pulmonary Circulation / Q000187:drug effects; D011897:Random Allocation; D014590:Uterine Contraction / Q000187:drug effects
D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D016718:Arachidonic Acid; D001241:Aspirin; D007213:Indomethacin